FEM1A is a candidate gene for polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age, and is characterized by infertility, hyperandrogenism and insulin resistance in skeletal muscle. There is evidence for a PCOS gene localized to chromosome 19p13.3. The FEMIA gene maps to chromosom...

Full description

Saved in:
Bibliographic Details
Published in:Gynecological endocrinology 2005-12, Vol.21 (6), p.330-335
Main Authors: Maher, Joseph F., Hines, Randall S., Futterweit, Walter, Crawford, Shawana, Lu, Deyin, Shen, Peidong, Oefner, Peter, Kazi, Mohammed, Wilson, James G., Subauste, Jose S., Cowan, Bryan D.
Format: Article
Language:English
Subjects:
Cell Cycle Proteins - genetics
Chromosomes, Human, Pair 19 - genetics
diabetes
fem-1
Female
genetics
Humans
hyperandrogenism
Open Reading Frames
Pilot Projects
Polycystic ovary syndrome
Polycystic Ovary Syndrome - genetics
Polymerase Chain Reaction
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age, and is characterized by infertility, hyperandrogenism and insulin resistance in skeletal muscle. There is evidence for a PCOS gene localized to chromosome 19p13.3. The FEMIA gene maps to chromosome 19p13.3 and is highly expressed in skeletal muscle. FEMIA is a homolog of fem-1, a sex-determination gene of Caenorhabditis elegans that controls masculinization. In a pilot study of Caucasian PCOS patients from our local clinic, we found that one of these five patients exhibited a heterozygous germline missense mutation in FEM1A, designated FEM1A*H500Y. This mutation alters an amino acid conserved from human to C. elegans, and was not found in any of 198 control chromosomes. This missense allele was not found in any of a separate group of 30 PCOS patients from a different regional ethnic background. Immunostaining of mouse ovary demonstrated that the mouse homolog of FEM1A is expressed in androgen-producing secondary interstitial cells, with a marked increase in expression after puberty, consistent with a key feature of PCOS - ovarian hyperandrogenism. In conclusion, FEM1A should be considered a candidate gene for PCOS, and more extensive analysis of FEM1A, both coding and regulatory sequences, is warranted in patients and families with PCOS.
ISSN:0951-3590
1473-0766
DOI:10.1080/09513590500431458